DexTech Medical Investor Relations Material
Latest events
Q3 2025
29 Apr, 2025
Q2 2025
27 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from DexTech Medical
Access all reports
DexTech Medical AB is a Sweden-based medical technology company specializing in the development of diagnostic and therapeutic solutions for oncology. The company focuses on creating proprietary products for the treatment and management of cancer, with an emphasis on prostate cancer and related conditions. The company is headquartered in Uppsala, Sweden, and its shares are listed on the Spotlight Stock Market.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
DEX
Country
🇸🇪 Sweden